The management of diabetic retinopathy and retinopathy of prematurity includes intravitreal anti–vascular endothelial growth factor (anti-VEGF) therapy, laser photocoagulation, corticosteroids, and surgical procedures, whereas glaucoma treatment primarily targets reduction in intraocular pressure [2,4,5,6,7,8]. Here, VEGFA is linked to glaucoma.